Comparison of a live attenuated and an inactivated varicella vaccine to boost the varicella-specific immune response in seropositive people 55 years of age and older

Author： Levine M.J.   Ellison M.C.   Zerbe G.O.   Barber D.   Chan C.   Stinson D.   Jones M.   Hayward A.R.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.18, Iss.25, 2000-06, pp. : 2915-2920

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Responses of varicella zoster virus (VZV)-specific immunity in seropositive adults after inhalation of inactivated or live attenuated varicella vaccine

By Terada K.   Niizuma T.   Ogita S.   Kataoka N.  

Vaccine, Vol. 20, Iss. 31, 2002-11 ,pp. : 3638-3643

Elsevier

Access to resources Recommend Favorite

Boosting immune response with a candidate varicella-zoster virus glycoprotein subunit vaccine

By Vafai A.  

Vaccine, Vol. 13, Iss. 14, 1995-10 ,pp. : 1336-1338

Elsevier

Access to resources Recommend Favorite

Immune response to varicella-zoster virus glycoproteins in guinea pigs infected with Oka varicella vaccine

By Sato H.   Kageyama S.   Imakita M.   Ida M.   Yamamura J.-i.   Kurokawa M.   Shiraki K.  

Vaccine, Vol. 16, Iss. 13, 1998-08 ,pp. : 1263-1269

Elsevier

Access to resources Recommend Favorite

Experience with live attenuated varicella vaccine (Oka strain) in healthy Japanese subjects; 10-year survey at pediatric clinic

By Ozaki T.   Nishimura N.   Kajita Y.  

Vaccine, Vol. 18, Iss. 22, 2000-05 ,pp. : 2375-2380

Elsevier

Access to resources Recommend Favorite

Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine

By Nolan T.   McIntyre P.   Roberton D.   Descamps D.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 281-289

Elsevier

Access to resources Recommend Favorite